Literature DB >> 23849445

Effect of immunodeficiency on MPV shedding and transmission.

James D Macy1, Frank X Paturzo, Susan R Compton.   

Abstract

C57BL/6 (B6) mice briefly shed low levels of MPV, and transmission is inefficient. To determine whether deficits in B or T cells or in interferon γ on a B6 background increased the duration of MPV shedding or transmission, B-cell-deficient (Igh), interferon-γ-deficient (Ifnγ), B- and T-cell-deficient (Rag), and B6 mice were inoculated with MPV. At 1 and 2 wk postinoculation (wpi), 11% to 94% of mice shed MPV. From 4 to 18 wpi, 80% to 100% of Rag mice and 0% of B6 and Ifnγ mice shed MPV; Igh mice sporadically shed MPV through 20 wpi. MPV was transmitted from B6 mice and Ifnγ mice at 2 to 4 wpi. Rag and Igh mice transmitted MPV to sentinels at all or most time points, respectively, between 2 to 16 wpi. Once transmission ceased from B6, Ifnγ, and Igh mice, breeding trios were setup and showed that MPV was transmitted to offspring in only one cage of Igh mice. In another experiment, MPV shedding ceased from B6, CD8-deficient (CD8), CD4-deficient (CD4), and T-cell-receptor-deficient (TCR) mice by 2, 6, 8, and 8 wpi, respectively. MPV was transmitted to sentinels only at 1 to 4 wpi. Mesenteric lymph nodes collected from 61% to 100% of B6, Ifnγ, TCR, CD4, CD8, and Rag mice were MPV DNA-positive. In conclusion, MPV transmission did not differ between mice deficient in T cell functions or Ifnγ and B6 mice. In contrast, B-cell deficiency posed an increased risk for MPV transmission in mice.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23849445      PMCID: PMC3725932     

Source DB:  PubMed          Journal:  J Am Assoc Lab Anim Sci        ISSN: 1559-6109            Impact factor:   1.232


  34 in total

Review 1.  Viruses and interferon: a fight for supremacy.

Authors:  Michael G Katze; Yupeng He; Michael Gale
Journal:  Nat Rev Immunol       Date:  2002-09       Impact factor: 53.106

2.  Detection of rodent parvoviruses by use of fluorogenic nuclease polymerase chain reaction assays.

Authors:  A J Redig; D G Besselsen
Journal:  Comp Med       Date:  2001-08       Impact factor: 0.982

3.  Mutations in T-cell antigen receptor genes alpha and beta block thymocyte development at different stages.

Authors:  P Mombaerts; A R Clarke; M A Rudnicki; J Iacomini; S Itohara; J J Lafaille; L Wang; Y Ichikawa; R Jaenisch; M L Hooper
Journal:  Nature       Date:  1992-11-19       Impact factor: 49.962

4.  Efficacy of three microbiological monitoring methods in a ventilated cage rack.

Authors:  Susan R Compton; Felix R Homberger; Frank X Paturzo; Judy MacArthur Clark
Journal:  Comp Med       Date:  2004-08       Impact factor: 0.982

5.  In vivo studies with an "orphan" parvovirus of mice.

Authors:  A L Smith; R O Jacoby; E A Johnson; F Paturzo; P N Bhatt
Journal:  Lab Anim Sci       Date:  1993-04

6.  Pathogenesis of mouse hepatitis virus infection in gamma interferon-deficient mice is modulated by co-infection with Helicobacter hepaticus.

Authors:  Susan R Compton; Lisa J Ball-Goodrich; Caroline J Zeiss; Linda K Johnson; Elizabeth A Johnson; James D Macy
Journal:  Comp Med       Date:  2003-04       Impact factor: 0.982

7.  Effector functions of antibody and CD8+ cells in resolution of rotavirus infection and protection against reinfection in mice.

Authors:  M M McNeal; K S Barone; M N Rae; R L Ward
Journal:  Virology       Date:  1995-12-20       Impact factor: 3.616

8.  Identification and propagation of a putative immunosuppressive orphan parvovirus in cloned T cells.

Authors:  M D McKisic; D W Lancki; G Otto; P Padrid; S Snook; D C Cronin; P D Lohmar; T Wong; F W Fitch
Journal:  J Immunol       Date:  1993-01-15       Impact factor: 5.422

9.  Mouse parvovirus infection potentiates rejection of tumor allografts and modulates T cell effector functions.

Authors:  M D McKisic; F X Paturzo; A L Smith
Journal:  Transplantation       Date:  1996-01-27       Impact factor: 4.939

10.  Characterization of mouse parvovirus infection by in situ hybridization.

Authors:  R O Jacoby; E A Johnson; L Ball-Goodrich; A L Smith; M D McKisic
Journal:  J Virol       Date:  1995-06       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.